The addition of a gut microbiome analysis to fecal occult blood testing improved the accuracy of standard colorectal cancer screening by more than 50-fold.
The expanded analysis not only...
Physicians can reduce liability and mitigate the risk of poor-quality drugs by taking advantage of a new federal law that tightens oversight on drug compounding facilities.
The ongoing...
GAITHERSBURG, MD. – A Food and Drug Administration advisory panel agreed that a device that thermally ablates the prostate gland using high-intensity focused ultrasound should not be approved for...
LAS VEGAS – Adult survivors of childhood cancer treated with high-dose cisplatin or high-dose ifosfamide are at markedly increased risk for chronic renal impairment, according to a large Dutch study...
A 55% jump in total expenditures for cancer treatment from 2001 to 2011 appears to reflect an increase in the number of patients, not an increase in the cost of treating those patients, according to...
Among patients with resectable esophageal adenocarcinoma, tumor stage after completion of neoadjuvant chemotherapy is a much more important predictor of survival than is initial tumor stage at...
Among patients with resectable esophageal adenocarcinoma, tumor stage after completion of neoadjuvant chemotherapy is a much more important predictor of survival than is initial tumor stage at...
Have you met an oncology hospitalist yet? If you haven’t, you probably will soon.
The latest offshoot of hospital medicine aims to take all the strengths of the hospitalist movement – increased...
Low-risk prostate cancer in older men is still being overtreated, according to two separate studies that examined the issue from different perspectives, both of which were published online July 14 in...
The use of minimally invasive surgery for appendectomy, colectomy, hysterectomy, and lung lobectomy varies widely in the United States, even though the complication rates were lower from each...